anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

187,441-187,500 of 319,975

filter-aware
05
AgroFresh | Results Presentation Deck | 18 slidesAgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
06
The slide acts as a press clipping montage to demonstrate recent momentum.AgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
07
The slide uses a table-like structure to map product categories to specific brand performance drivers.AgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
08
The slide uses a stacked bar chart for composition and a waterfall chart for the year-over-year growth bridge.AgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
09
The slide uses a stacked bar chart for composition and a waterfall chart for the growth bridge.AgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
10
The slide uses a background map to anchor regional performance commentary.AgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
11
The slide uses a stacked bar chart for regional revenue composition and a waterfall chart for growth attribution.AgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
12
The slide uses a stacked bar chart for regional revenue composition and a waterfall chart for year-over-year growth attribution.AgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
13
AgroFresh | Results Presentation Deck | 18 slidesAgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
14
Includes a bar chart for Adjusted EBITDA and text-based summaries for Net Income and Adjusted EBITDA performance.AgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations Beat · KPI OverviewLoop · Logic Chain1 hit
15
Includes detailed footnotes explaining non-recurring items and specific financial adjustments.AgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations 1 hit
16
AgroFresh | Results Presentation Deck | 18 slidesAgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations Beat · Summary1 hit
17
AgroFresh | Results Presentation Deck | 18 slidesAgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations 1 hit
18
Standard SEC Regulation G disclosure for non-GAAP financial measures.AgroFresh | Results Presentation Deck | 18 slides · AgroFresh
Conference presentation Investor relations 1 hit
01
Slide 1
Allego | Results Presentation Deck | 22 slidesAllego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Humble Origins1 hit
02
Allego | Results Presentation Deck | 22 slidesAllego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Humble Origins1 hit
03
Allego | Results Presentation Deck | 22 slidesAllego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Humble Origins1 hit
04
The slide uses a hybrid structure combining a process/value chain flow with data tables and descriptive lists.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Rising Success1 hit
05
Allego | Results Presentation Deck | 22 slidesAllego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Rising Success1 hit
06
The slide uses a split-column layout to contrast financial performance with operational milestones.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Rising Success1 hit
07
The slide uses a numbered list format (01, 02, 03) to structure the key takeaways about the partner company MOMA.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Rising Success1 hit
08
Allego | Results Presentation Deck | 22 slidesAllego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Rising Success1 hit
09
Uses BNEF data to compare EV Car Parc and Public Fast Charging Power Demand.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Rising SuccessLoop · Why Now1 hit
10
The slide uses a vertical timeline structure to detail specific partnership deals and their associated site/charging point commitments.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Rising SuccessLoop · Why Now1 hit
11
Allego | Results Presentation Deck | 22 slidesAllego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · The Breakthrough1 hit
12
The slide uses a split layout with charts on the left and key takeaways on the right.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · The Breakthrough1 hit
13
The slide uses a two-column layout: left side presents quantitative growth metrics (bar charts), right side presents qualitative strategic takeaways.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · The Breakthrough1 hit
14
The slide uses a split layout: a line chart on the left and a numbered list of strategic actions on the right.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · The Breakthrough1 hit
15
Allego | Results Presentation Deck | 22 slidesAllego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · The Breakthrough1 hit
16
The slide uses a waterfall-like progression to show growth in charging ports.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · The Breakthrough1 hit
17
The slide uses a mix of metrics and partner logos to validate the company's financing strategy.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
18
Utilization rate calculation note provided in footer.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
19
Allego | Results Presentation Deck | 22 slidesAllego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
20
Allego | Results Presentation Deck | 22 slidesAllego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
21
The table provides a detailed breakdown of adjustments to reconcile IFRS loss to non-IFRS metrics like EBITDA and Free Cash Flow.Allego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
22
Allego | Results Presentation Deck | 22 slidesAllego | Results Presentation Deck | 22 slides · Allego
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
01
Slide 1
The slide uses a global map background and patient portraits to emphasize the scope and human impact of the company's mission.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
02
AN2 Therapeutics | Investor Presentation Deck | 25 slidesAN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
03
AN2 Therapeutics | Investor Presentation Deck | 25 slidesAN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
04
The slide uses a grid layout to display headshots, names, titles, and company logos for both management and board members.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
05
The slide uses a split-layout with company mission on the left and product details on the right.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
06
The slide uses a Gantt-style visualization for clinical trial progress.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
07
AN2 Therapeutics | Investor Presentation Deck | 25 slidesAN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
08
AN2 Therapeutics | Investor Presentation Deck | 25 slidesAN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
Uses a nested Venn/funnel diagram to illustrate market segmentation.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a two-part table structure to contrast standard care with refractory care, emphasizing toxicity and lack of FDA approval for many agents.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide presents a balanced view, showing both efficacy and significant safety/tolerability concerns for the competitor drug.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
12
Scientific illustration showing molecular binding interaction.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
EBO = Epetraborole; MAC = Mycobacterium avium complex; MIC = Minimum Inhibitory Concentration.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
The chart demonstrates dose-dependent efficacy of Epetraborole (EBO) against M. avium 2285 (R).AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
The charts demonstrate dose-dependent efficacy and synergy between EBO and SoC.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
16
Includes a timeline diagram of the study design and bulleted clinical outcomes.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
17
The slide highlights the therapeutic potential of the drug by showing superior accumulation at the site of infection.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Traction1 hit
18
The slide outlines a seamless transition between Phase 2 and Phase 3 trials for a specific drug candidate.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
19
Uses a funnel-like diagram to represent market segments.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Business Model1 hit
20
The table uses checkmarks and X marks to denote performance against specific clinical criteria.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Business Model1 hit
21
QIDP = Qualified Infectious Disease Product DesignationAN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Business Model1 hit
22
The timeline shows clinical trial phases (Chronic Tox, Phase 1b, Ph 2/3 TR-MAC, Ph 1 Japan, Ph 2/3 Topline Data).AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations Beat · Business Model1 hit
23
AN2 Therapeutics | Investor Presentation Deck | 25 slidesAN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit
24
The slide uses a split-layout with a company mission statement on the left and product-specific details on the right.AN2 Therapeutics | Investor Presentation Deck | 25 slides · AN2 Therapeutics
Pitch deck Investor relations 1 hit